Cargando…
SUN-LB64 Urine Phosphoethanolamine Is an Underutilized Biomarker for Hypophosphastasia
Hypophosphatasia (HPP) is a rare disease caused by a loss-of-function mutation in the ALPL gene leading to a deficiency in the tissue-non-specific isoenzyme alkaline phosphatase (ALP) and excess of extracellular inorganic pyrophosphate (PPi) and pyridoxal 5’phosphate (PLP). Patients with HPP have a...
Autores principales: | Shajani-Yi, Zahra, Ayala-Lopex, Nadia, Black, Margo, Dahir, Kathryn McCrystal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209251/ http://dx.doi.org/10.1210/jendso/bvaa046.2335 |
Ejemplares similares
-
SAT-382 Pyridoxal 5’-Phosphate Cerebrospinal Fluid Abnormalities in Hyopophosphatasia Before and After Enzyme Replacement Therapy
por: Wright, Jordan J, et al.
Publicado: (2020) -
SUN-LB092 The Role of the Modified Performance-Oriented Mobility Assessment Tool in the Evaluation of Gait in Adults with Hypophosphatasia
por: Dahir, Kathryn, et al.
Publicado: (2019) -
SAT-LB64 Teriparatide and Its Bone Healing Power
por: Joseph, Aneeta J, et al.
Publicado: (2020) -
SUN-LB67 Revisit Serum Calcium Correction
por: Li, Yulong, et al.
Publicado: (2020) -
SUN-LB66 Oral Risedronate Treatment in Children With Osteogenesis Imperfecta
por: Nguyen, Antoine T, et al.
Publicado: (2020)